This brand name is authorized in Japan.
The drug LUCIDRIL contains one active pharmaceutical ingredient (API):
1
|
UNII
5BK3070BDY - MECLOFENOXATE HYDROCHLORIDE
|
|
Meclofenoxate is a cholinergic nootropic with antianoxic effect whether anoxia is provoked by defect or misuse of oxygen. Meclofenoxate improves extraction and utilization of glucose from the brain which allows maintenance of storage of energy for the neuron even in case of O2 deficiency or aging. In elderly patients, meclofenoxate has been shown to improve performance on certain memory tests. Meclofenoxate also increases cellular membrane phospholipids. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| LUCIDRIL Film coated tablet | MPI, Generic | Web Search |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| JP | 医薬品医療機器総合機構 | 2190003F1170 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.